HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER

被引:3
作者
BICHEL, P
JAKOBSEN, A
ORNTOFT, TF
机构
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, INST PATHOL, DEPT CLIN CHEM, DK-8000 AARHUS, DENMARK
[2] VEJLE CENT HOSP, INST PATHOL, AARHUS, DENMARK
[3] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, AARHUS, DENMARK
关键词
CA-125; HISTOCHEMICAL DISTRIBUTION; OVARY CARCINOMA; PROGNOSIS;
D O I
10.1111/j.1525-1438.1991.tb00040.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study comprises 66 patients with stage Ill and IV serous ovarian carcinoma While the percentage of CA-125 positive cells and the staining intensity showed no correlation to patient survival, the pattern of CA-125 distribution, membranous versus cytoplasmic, was significantly correlated to survival. In accordance with other observations on switching of the antigen reaction f rom membrane to cytoplasm with increasing grade of atypia or malignancy, patients with membrane positive CA-125 tumors had a significantly better prognosis than did patients with CA-125 in the cytoplasm. Furthermore, there was excellent agreement between, on the one hand, the binding pattern of CA-125 and, on the other, the ploidy of the tumor cells and the HGI histopathologic grading index, both previously shown to be of prognostic significance.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [1] CA-125 IN OVARIAN-CANCER
    VANDERBURG, MEL
    LAMMES, FB
    VERWEIJ, J
    NETHERLANDS JOURNAL OF MEDICINE, 1992, 40 (1-2) : 36 - 51
  • [2] Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
    Xia Xu
    Yan Wang
    Fang Wang
    Lizhou Jia
    Yiqin Zhou
    Fei Deng
    Junwei Qu
    Bifang Zhou
    Aifeng Meng
    Bole Fu
    Xiaoxiang Chen
    Zhiying Qian
    Jinhua Wang
    Journal of Ovarian Research, 6
  • [3] Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
    Xu, Xia
    Wang, Yan
    Wang, Fang
    Jia, Lizhou
    Zhou, Yiqin
    Deng, Fei
    Qu, Junwei
    Zhou, Bifang
    Meng, Aifeng
    Fu, Bole
    Chen, Xiaoxiang
    Qian, Zhiying
    Wang, Jinhua
    JOURNAL OF OVARIAN RESEARCH, 2013, 6
  • [4] IMMUNOSUPPRESSIVE ACIDIC PROTEIN AND CA-125 LEVELS IN PATIENTS WITH OVARIAN-CANCER
    CASTELLI, M
    BATTAGLIA, F
    SCAMBIA, G
    PANICI, PB
    FERRANDINA, G
    MILEO, AM
    MANCUSO, S
    FERRINI, U
    ONCOLOGY, 1991, 48 (01) : 13 - 17
  • [5] CA-125 AUC as a new prognostic factor for patients with ovarian cancer
    Mano, A
    Falcao, A
    Godinho, I
    Santos, J
    Leitao, F
    Oliveira, C
    Caramona, M
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 529 - 534
  • [6] Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer
    Mury, Dina
    Woelber, Linn
    Jung, Sabine
    Eulenburg, Christine
    Choschzick, Matthias
    Witzel, Isabell
    Schwarz, Joerg
    Jaenicke, Fritz
    Mahner, Sven
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (07) : 1131 - 1137
  • [7] Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer
    Dina Mury
    Linn Woelber
    Sabine Jung
    Christine Eulenburg
    Matthias Choschzick
    Isabell Witzel
    Joerg Schwarz
    Fritz Jaenicke
    Sven Mahner
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1131 - 1137
  • [8] SERUM TETRANECTIN AND CA-125 USED TO MONITOR THE COURSE OF TREATMENT IN OVARIAN-CANCER PATIENTS
    HOGDALL, CK
    HORDING, U
    NORGAARDPEDERSEN, B
    TOFTAGERLARSEN, K
    CLEMMENSEN, I
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1994, 57 (03): : 175 - 178
  • [9] CA-125 Level as a Prognostic Indicator in Type I and Type II Epithelial Ovarian Cancer
    Chen, Xiaoxiang
    Zhang, Jing
    Cheng, Wenjun
    Chang, Doo Young
    Huang, Jianfei
    Wang, Xuan
    Jia, Lizhou
    Rosen, Daniel G.
    Zhang, Wei
    Yang, Da
    Gershenson, David M.
    Sood, Anil K.
    Bast, Robert C., Jr.
    Liu, Jinsong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (05) : 815 - 822
  • [10] The prognostic value of pretherapeutic tetranectin and CA-125 in patients with relapse of ovarian cancer
    Deng, XH
    Hogdall, EVS
    Hogdall, CK
    Norgaard-Pedersen, B
    Jorgensen, M
    Nielsen, H
    Engelholm, SAA
    GYNECOLOGIC ONCOLOGY, 2000, 79 (03) : 416 - 419